ATFX Illuminates the Future with 2025 Annual Gala Dinner
ZTO to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 18, 2025 U.S. Eastern Time
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)
CNPC's Well Shendi Take-1 reaches 10,910-meter milestone
Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets
"The Future of Travel": Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025
ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

